Search Menu

New PAASP publication: ‘The reproducibility crisis in preclinical research – lessons to learn from clinical research’

In this article, Laia Pedro-Roig and Christoph Emmerich discuss ways and measures how preclinical research and development (especially in its confirmatory phase) would benefit from adapting some of the internationally accepted quality standards and principles used in clinical research. In contrast to clinical research, with generally …

Read more

PAASP is part of the BMBF-funded GOT-IT (‘Guidelines On Target Validation for Innovative Therapeutics’) Project

Medical progress and continued supply of innovative medicines can only be guaranteed by continuous research and development of new active drugs and therapeutics. The most important starting point for the identification of new drugs are disease-modifying targets. Thus, the proper validation of pharmaceutically relevant targets based …

Read more

New PAASP member

We are delighted to announce that Malgorzata Pietraszek has joined our PAASP Team. Malgorzata has over 20 years of experience in CNS pharmacology acquired in both pharmaceutical industry and academic environments. Malgorzata holds a PhD from the Institute of Pharmacology Polish Academy of Sciences (PAS) in …

Read more

Webinar bei Martin Michel

Prof. Dr. Martin Michel presented the November Cohen Veterans Bioscience Webinar on November 16th from 12 pm noon – 1 pm ET. Martin shared several interesting but also funny insights to the current crisis in the scientific community. He created awareness about the scope of the problem and …

Read more

Scroll Up